Oxcarbazepine (All indications)

Ear, face and neck anomalies

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S9057
R30914		 Artama (Oxcarbazepine), 2005 Ear, face and neck 1st trimester retrospective cohort (registry) unexposed, sick Adjustment: No 1.90 [0.09;39.89] C 0/99   2/939 2 99
ref
Total 1 studies 1.90 [0.09;39.89] 2 99
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Artama (Oxcarbazepine), 2005Artama, 2005 1 1.90[0.09; 39.89]2990%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Oxcarbazepine;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.90[0.09; 39.89]299 -NAArtama (Oxcarbazepine), 2005 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 1.90[0.09; 39.89]299 -NAArtama (Oxcarbazepine), 2005 1 Tags Adjustment   - No  - No 1.90[0.09; 39.89]299 -NAArtama (Oxcarbazepine), 2005 1 All studiesAll studies 1.90[0.09; 39.89]299 -NAArtama (Oxcarbazepine), 2005 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls 1.90[0.09; 39.89]299 -NAArtama (Oxcarbazepine), 2005 10.510.01.0